[1]
|
Labki, W.W. and Rosenbereg, S.R. (2020) Chronic Obstructive Pulmonary Disease. Annals of Internal Medicine, 173, ITC17-ITC32. https://doi.org/10.7326/AITC202008040
|
[2]
|
Bafadhel, M., Davies, L., Calverley, P.M., Aaron, S.D., Brightling, C.E. and Pavord, I.D. (2014) Blood Eosinophil Guided Prednisolone Therapy for Exacerbations of COPD: A Further Analysis. European Respiratory Journal, 44, 789-791. https://doi.org/10.1183/09031936.00062614
|
[3]
|
中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版) [J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205.
|
[4]
|
Barnes, P.J. (2019) Inflammatory Endotypes in COPD. Allergy, 74, 1249-1256. https://doi.org/10.1111/all.13760
|
[5]
|
张扬, 辛璐. 急性心肌梗死合并多支血管病变病人首次PCI术后未干预病变斑块进展的危险因素分析[J]. 中西医结合心脑血管病杂志, 2021, 19(10): 1718.
|
[6]
|
Hogan, S.P., Rosenberg, H.F., Moqbel, R., Phipps, S., Foster, P.S., Lacy, P., et al. (2008) Eosinophils: Biological Properties and Role in Health and Disease. Clinical & Experimental Allergy, 38, 709-750. https://doi.org/10.1111/j.1365-2222.2008.02958.x
|
[7]
|
George, L. and Brightling, C.E. (2016) Eosinophilic Airway Inflammation: Role in Asthma and Chronic Obstructive Pulmonary Disease. Therapeutic Advances in Chronic Disease, 7, 34-51. https://doi.org/10.1177/2040622315609251
|
[8]
|
Woodruff, P.G., Modrek, B., Choy, D.F., et al. (2009) T-Helper Type 2-Driven Inflammation Defines Major Subphenotypes of Asthma. American Journal of Respiratory and Critical Care Medicine, 180, 388-395. https://doi.org/10.1164/rccm.200903-0392OC
|
[9]
|
Robinson, D., Humbert, M., Buhl, R., et al. (2017) Revisiting Type 2-High and Type 2-Low Airway Inflammation in Asthma: Current Knowledge and Therapeutic Implications. Clinical & Experimental Allergy, 47, 161-175. https://doi.org/10.1111/cea.12880
|
[10]
|
Barnes, P.J. (2016) Inflammatory Mechanisms in Patients with Chronic Obstructive Pulmonary Disease. Journal of Allergy and Clinical Immunology, 138, 16-27. https://doi.org/10.1016/j.jaci.2016.05.011
|
[11]
|
Tashkin, D.P. and Wechsler, M.E. (2018) Role of Eosinophils in Airway Inflammation of Chronic Obstructive Pulmonary Disease. The International Journal of Chronic Obstructive Pulmonary Disease, 13, 335-349. https://doi.org/10.2147/COPD.S152291
|
[12]
|
Sugawara, R., Lee, E.J., Jang, M.S., Jeun, E.J., Hong, C.P., Kim, J.H., et al. (2016) Small Intestinal Eosinophils Regulate Th17 Cells by Producing IL-1 Receptor Antagonist. Journal of Experimental Medicine, 213, 555-567. https://doi.org/10.1084/jem.20141388
|
[13]
|
Berek, C. (2016) Eosinophils: Important Players in Humoral Immunity. Clinical and Experimental Immunology, 183, 57-64. https://doi.org/10.1111/cei.12695
|
[14]
|
Marichal, T., Mesnil, C. and Bureau, F. (2017) Homeostatic Eosinophils: Characteristics and Functions. Frontiers in Medicine (Lausanne), 4, Article No. 101. https://doi.org/10.3389/fmed.2017.00101
|
[15]
|
Wechsler, M.E., Munitz, A., Ackerman, S.J., Drake, M.G., Jackson, D.J., Wardlaw, A.J., et al. (2021) Eosinophils in Health and Disease: A State-of-the-Art Review. Mayo Clinic Proceedings, 96, 2694-2707. https://doi.org/10.1016/j.mayocp.2021.04.025
|
[16]
|
Hospers, J.J., Schouten, J.P., Weiss, S.T., et al. (1999) Asthma Attacks with Eosinophilia Predict Mortality from Chronic Obstructive Pulmonary Disease in a General Population Sample. American Journal of Respiratory and Critical Care Medicine, 160, 1869-1874. https://doi.org/10.1164/ajrccm.160.6.9811041
|
[17]
|
Bafadhel, M., McKenna, S., Terry, S., et al. (2012) Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Placebo-Controlled Trial. American Journal of Respiratory and Critical Care Medicine, 186, 48-55. https://doi.org/10.1164/rccm.201108-1553OC
|
[18]
|
Siddiqui, S.H., Guasconi, A., Vestbo, J., Jones, P., Agusti, A., Paggiaro, P., Wedzicha, J.A. and Singh, D. (2015) Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 192, 523-525. https://doi.org/10.1164/rccm.201502-0235LE
|
[19]
|
Lipson, D.A., Barnhart, F., Brealey, N., Brooks, J., Criner, G.J., Day, N.C., et al. (2018) Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. The New England Journal of Medicine, 378, 1671-1680. https://doi.org/10.1056/NEJMoa1713901
|
[20]
|
Miravitlles, M., Calle, M., Molina, J., Almagro, P., Gomez, J.T., Trigueros, J.A., et al. (2022) Spanish COPD Guidelines (GesEPOC) 2021: Updated Pharmacological Treatment of Stable COPD. Archivos de Bronconeumología, 58, 69-81. https://doi.org/10.1016/j.arbres.2021.03.005
|
[21]
|
Singh, D., Agusti, A., Martinez, F.J., Papi, A., Pavord, I.D., Wedzicha, J.A., et al. (2022) Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review. American Journal of Respiratory and Critical Care Medicine, 206, 17-24. https://doi.org/10.1164/rccm.202201-0209PP
|
[22]
|
Park, H.Y., Chang, Y., Kang, D., et al. (2021) Blood Eosinophil Counts and the Development of Obstructive Lung Disease: The Kangbuk Samsung Health Study. European Respiratory Journal, 58, Article ID: 2003823. https://doi.org/10.1183/13993003.03823-2020
|
[23]
|
Barnes, N.C., Sharma, R., Lettis, S., et al. (2016) Blood Eosinophils as a Marker of Response to Inhaled Corticosteroids in COPD. European Respiratory Journal, 47, 1374-1382. https://doi.org/10.1183/13993003.01370-2015
|